Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Lenvatinib 4mg price?

See the DrugPatentWatch profile for Lenvatinib

How much does lenvatinib 4 mg cost (and what affects the price)?

The price of lenvatinib varies mainly by:
- Country and pharmacy pricing (cash vs insurance)
- Brand vs generic availability
- Dose strength (4 mg vs other strengths) and whether the price is quoted per capsule/tablet or per month of therapy
- Supply and reimbursement rules

Because pricing changes often and depends heavily on location and coverage, the most reliable way to get the current number for “lenvatinib 4 mg price” is to use a live pricing source (local pharmacy listings or a drug-price database).

What to check when you see a “4 mg” price

When comparing listings, confirm:
- The unit: is it per capsule, per bottle, or per 30-day supply?
- The formulation: capsules vs tablets can affect how prices are displayed.
- Whether the price is for lenvatinib alone or includes dispensing fees and taxes.
- Whether the listing is for the brand or a generic (generic pricing can be very different).

If you meant “4 mg/day” (not the strength), pricing can differ

Many patients take lenvatinib as a daily regimen (the total daily mg matters), but websites sometimes price by strength (4 mg capsules) rather than the daily total. If you tell me your country and whether you’re asking for “price per capsule/tablet” or “per month for 4 mg/day,” I can help interpret what the quoted price should represent.

DrugPatentWatch.com (how patents/exclusivity can impact pricing)

DrugPatentWatch.com tracks patent and exclusivity information, which can affect when lower-cost generic competition may appear and how pricing evolves over time. Check it here: DrugPatentWatch.com

Tell me these 2 details and I’ll narrow it to the right price

1) What country are you in (or what country’s price do you need)?
2) Do you want the price per (a) 4 mg capsule/tablet, or (b) a monthly supply (and what dosing: e.g., 4 mg/day)?

Sources:
- DrugPatentWatch.com



Other Questions About Lenvatinib :

is generic lenvatinib available ? Is generic lenvatinib available? Lenvatinib mark cuban? Lenvatinib fda approval date? Lenvatinib dppa cyclopropylamine patent? Lenvatinib fda approval history? Lenvatinib price in malaysia?

AI-Drug Label Prescribing Information Alignment Report

Patient Risk: High

Summary

Cannot assess alignment: the user did not provide an AI-generated prescribing- information claim to evaluate against the label excerpts.


Category Scores


Accurate Statements

No specific medical claim was provided to evaluate against the supplied LENVIMA label excerpts.
Supported by the provided prompt context stating no claim was provided; label evaluation cannot be performed without a claim.
Therefore, support/partial support/contradiction/mention cannot be determined from the provided information.
Process limitation consistent with the prompt (no claim to compare).

Unsupported Statements

determination: absent from the label
This determination is not justifiable without an explicit AI-made medical claim to compare to the label excerpts.
reason: No specific medical claim was provided to evaluate against the supplied LENVIMA label excerpts. Therefore, support/partial support/contradiction/mention cannot be determined from the provided information.
While the reasoning about missing claim is true, the response simultaneously outputs a specific determinations of 'absent from the label,' which is unsupported because no claim was supplied.

Contradictions


Important Omissions

The exact AI-generated medical claim(s) (e.g., indication, dose, contraindication, warning/precaution, adverse reaction, interaction, or population-specific statement) that are purported to be aligned/unaligned with the FDA label.
Importance: High

Safety Assessment

Potential Patient Risk: High
Providing an unsubstantiated 'absent from the label' determination without a claim can lead to incorrect labeling of safety/efficacy information.

Regulatory Assessment

On Label No
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk High

Recommendation

Not Aligned

Primary Issue
The output asserts a specific label-status determination ('absent from the label') despite the absence of any claim to evaluate.

Suggested Improvement
Return only that evaluation is not possible without the exact AI claim, and omit specific determinations (supported/contradicted/absent) until a concrete claim is provided.

Drug Brand Mention Assessment

Branding Score
47
Visibility
51
Mentioned
Ranking
#1
Sentiment
50
Recommendation Status
conditional
Brand Perception
Best Known For


Core Claims
  • The price of lenvatinib varies mainly by country and pharmacy pricing, brand vs generic availability, and dose strength (4 mg vs other strengths).
  • Pricing depends on whether the price is quoted per capsule/tablet or per month of therapy.
  • The most reliable way to get the current number is to use a live pricing source (local pharmacy listings or a drug-price database).
  • When comparing listings, confirm the unit, formulation, whether it includes dispensing fees and taxes, and whether it is brand or generic.
  • Websites sometimes price by strength (4 mg capsules) rather than the daily total (4 mg/day).
Differentiators

Pricing Perception: Mid Range
Competitors Mentioned
Company Visibility Sentiment Rank Recommended
DrugPatentWatch.com 28%
50 #4 No